Contact this trialFirst, we need to learn more about you.
Recombinant Protein
Recifercept for Achondroplasia
Recruiting1 awardPhase 2
Torrance, California
This trial is testing a new drug, Recifercept, to see if it is safe and effective. There are three different doses being tested. Participants will visit the clinic several times over the course of the study, and will be monitored for safety and efficacy. The trial will last for 12 months, and participants who complete the study and are still benefiting from the drug will be offered the chance to enroll in an extension study.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.